MEDLIVE (02192) has announced that Ernst & Young is scheduled to retire as the company's auditor following the conclusion of the Annual General Meeting on May 15, 2026. As the company and its current auditor, Ernst & Young, were unable to reach an agreement on the audit fees for the financial year ending December 31, 2026, MEDLIVE initiated a tender process for a new external auditor in March 2026. Following the recommendation of the company's audit committee on April 17, 2026, the Board of Directors has resolved to propose the appointment of Deloitte Touche Tohmatsu as the new auditor. This appointment is intended to be effective from the conclusion of the 2026 Annual General Meeting until the end of the next subsequent Annual General Meeting. The proposed appointment is subject to approval by shareholders at the 2026 Annual General Meeting.